Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention
Top Cited Papers
- 28 January 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (3) , 363-369
- https://doi.org/10.1161/01.cir.0000053730.47739.3c
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular EventsCirculation, 2003
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular EventsNew England Journal of Medicine, 2002
- Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in WomenCirculation, 2002
- Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary RevascularizationCirculation, 2001
- Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery DiseaseNew England Journal of Medicine, 2000
- C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in menPublished by Oxford University Press (OUP) ,2000
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A SubstudyJournal of the American College of Cardiology, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable AnginaNew England Journal of Medicine, 1994